Bunzl group announce the reinstatement of the 2019 final dividend of 35.8p per share
As highlighted in the Company's first quarter trading statement issued at the beginning of April, due to the heightened uncertainty at that time relating to the macroeconomic environment in which the Company was trading, the Bunzl Board decided it would no longer propose a final dividend for the year ended 31 December 2019 at the Annual General Meeting held on 15 April 2020. However, we stated at the time that the Board recognised the importance of dividends to shareholders and, as such, intended to consider the appropriateness, quantum and timing of an additional interim dividend payment relating to the year ended 31 December 2019 when the Board had a clearer view of the effects of Covid-19 on the Company's business.
As a result of the better than expected trading performance during the first half of the year and after due and careful consideration the Board has decided to reinstate and pay the final dividend for the year ended 31 December 2019 at the same level as originally proposed (35.8p). As it is no longer possible for this dividend to be approved by shareholders at the Annual General Meeting, it will be paid as an additional interim dividend for the year ended 31 December 2019 on 16 November 2020 to those shareholders on the register on 16 October 2020.
The Board has also decided to increase the 2020 interim dividend by 1.9% to 15.8p. Shareholders will again have the opportunity to participate in our dividend reinvestment plan in relation to both of these dividends.
Other financial highlights include:
Strong and resilient performance despite Covid-19 challenges with revenue up 7.0%, 6.7% at constant exchange rates, and double digit increases in adjusted operating profit and adjusted earnings per share
Adjusted profit before income tax up 16.6% at constant exchange rates to £306.8 million
Operating margin 7.0%, up 30 basis points on a reported basis and 40 basis points at constant exchange rates
Return on average operating capital and return on invested capital increased to 39.7% and 14.4% respectively
Continued strong cash conversion of 112% with net debt to EBITDA only 1.6x (1.9x at end of 2019)
Acquisition activity has resumed with the proposed acquisition of MCR Safety and Abco Kovex announced today and a number of ongoing discussions taking place with a promising pipeline of potential opportunities
The Chesnara financial results support the continued growth of the interim dividend to 7.65p per share (2019 interim: 7.43p per share)Read more
The Smiths Group Board maintains a progressive dividend policy, aiming to increase dividends in line with long-term underlying growth in earnings and cash-flow. The policy enables them to retain sufficient cash-flow to finance investment in the drivers of growth and meet financial obligations. In setting the level of dividend payments, the Board considers prevailing economic conditions and future investment plans, along with the objective to maintain minimum dividend cover* of around 2 times.Read more
The Hansard Board has proposed a final dividend of 2.65p per share, the same level as last year. In making this proposal, the Board has carefully considered its current financial position and future outcomes under a range of plausible adverse scenarios taking into account Covid-19.Read more
The PZ Cussons Board is recommending a final dividend of 3.13p (2019: 5.61p) per share, making a total dividend for the year of 5.80p (2019: 8.28p) per share. The gross amount for the proposed final dividend is £13.1 million (2019: £23.5 million).Read more
On 2 April 2020 the board announced that it had decided to cancel the 2020 interim dividend, which would have been paid on 22 April 2020, recognising the significant challenges faced by businesses and individuals and consistent with the purpose of helping the people and businesses of Britain.Read more
The Alliance Pharma board have announced that, after suspending the final dividend payment for 2019 in response to the COVID-19 pandemic, it is declaring an interim dividend payment of 0.536p per share for 2020, in line with that for 2019. The Board will continue to assess the level of future cash distributions having regard to overall business performance and future outlook, in light of the global uncertainty created by COVID-19Read more
The North American Income Trust revenue return per Ordinary share rose by 27.0% from 5.35p to 6.80p. The Board has declared a second quarterly dividend of 1.8p per share, giving total dividends for the first half of the year to 31 January 2021 of 3.6p (2020 - 3.4p), a 5.9% increase. The second quarterly dividend is payable on 30 October 2020 to shareholders on the register on 2 October 2020.Read more
The Brooks Macdonald Board has recommended a final dividend of 32.0p (FY19: 32.0p) which, subject to approval by shareholders at the AGM, will result in total dividends for the year of 53.0p (FY19: 51.0p). This represents an increase of 3.9% on the previous year and reaffirms the Board's confidence in the strength of the business even in the context of the COVID-19 pandemic, and a commitment to a progressive dividend policy. The final dividend will be paid on 6 November 2020 to shareholders on the register at the close of business on 25 September 2020.Read more
The Clinigen Directors are proposing to increase the final dividend to 5.46p per share (2019: 4.75p), resulting in a 14% increase in the full year dividend to 7.61p per share (2019: 6.7p).Read more
The Hilton Food Directors have approved the payment of an interim dividend of 7.0p per share payable on 27 November 2020 to shareholders who are on the register at 30 October 2020. This interim dividend, amounting to £5.7m has not been recognised as a liability in these interim financial statements. It will be recognised in shareholders' equity in the 53 weeks to 3 January 2021.Read more